London professor appointed chairman of Europe medicinal cannabis body
A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European...
Partnership to develop new technology for delivery of medicinal cannabis
Curtin University and Perth-based company, Little Green Pharma Ltd, have joined forces to develop a range of new medical cannabis products.
The partnership aims to...
Nordik Leaf: looking at Canada’s cannabis quality problem
Despite widespread reform in Canada challenges still exist which must be overcome - including cannabis quality.
In cannabis, there are very few topics so polarising...
Mile High Labs: Making ‘retail ready’ CBD a reality
How can Mile High Labs help you with your supply? Christian Hendriksen, VP of International Expansion, showcases what they have to offer.
As the demand...
World’s first government supported medical cannabis incubator in Israel
Leading medical cannabis researcher, Israel, will be host to the world’s first government supported cannabis technology incubator.
OurCrowd, Perrigo and BOL have won the Israeli...
Black Swan: rare Jamaican cannabis strain could treat pancreatic cancer
In 2019 a flavonoid of cannabis – Caflanone (FBL-03G) – was granted Orphan drug status by the United States Food and Drug Administration. Now,...
Handpicked Jobs: talent for the cannabis industry
Handpicked Jobs is a cannabis-specific recruitment platform connecting industry pioneers with exceptional talent.
With global cannabis laws moving towards legalisation, and huge investment flowing into...
CannaVerde: delivering the full therapeutic potential of cannabinoids
CannaVerde's goal is to become a low cost, high quality producer of medical cannabis extracts, with a further focus on product formulation and development.
Through...
EXMceuticals sets sights on Europe and US combined cannabis markets
EXMceuticals is an up and coming player on the market with high ambitions and the potential of becoming the lowest cost producer of high-grade...
Symtomax CBD oral tab: innovative delivery for cannabinoids
Symtomax has created its very own CBD oral tab as a novel and innovative delivery form for cannabinoids.
Over the last few years the global...
The UK Cannabis Report: legal cannabis market to reach £2.31bn by 2024
A new report from Prohibition Partners forecasts the UK legal cannabis market to reach £2.31bn by 2024.
Prohibition Partners has produced The UK Cannabis Report...
CMC calls on UK government to review medical cannabis policy
Today, the Centre for Medicinal Cannabis (CMC) is calling on the UK government to urgently review medical cannabis policy relating to cannabis access.
The call...
Leading UK oncologist to unlock medical cannabis market opportunities
The UK's leading oncologist has joined Block Commodities Ltd to unlock opportunities in the CBD wellness and medical cannabis market.
Block Commodities, a commodity-focussed trading...
Breakthrough discovery: cannabis compound 30 times stronger than THC
In a breakthrough for cannabis research scientists have discovered a cannabinoid in the cannabis plant that is potentially 30 times stronger than THC.
Cannabis has...
Partnership for new drugs derived from cannabis to prevent vision loss
A new partnership has been formed to license two new synthetic drug candidate formulations derived from cannabis.
The cannabis research program at the University of...
The story of The Valens Company: bringing out the best in cannabis
A group of deeply passionate cannabis professionals at The Valens Company, driven by a belief that there are more inclusive and safer delivery methods...
Eqalis: turning horticultural knowledge into a billion dollar venture
Eqalis Pharmaceuticals Limited combines horticultural expertise with a passion for wellness to produce innovative medical cannabis products.
The sunny orchards of the Bay of Plenty...
First medical cannabis Exchange Traded Fund in Europe launched
The Medical Cannabis and Wellness UCITS ETF (CBDX) is the first medical cannabis Exchange Traded Fund to be listed in Europe.
European company, HANetf, has...
Introducing the Medical Cannabis Network Editorial Advisory Board
To kick off 2020, MCN is bringing you our brand new, free to access, quarterly publication. But before we do, let's introduce our Editorial...
Canngea: driving medical cannabis excellence in Australia
“Canngea is Australia’s only medical cannabis contract manufacturing organisation, using proven indoor grow technology to make consistent high-quality products at a competitive price”.
Australian startup,...
